Medication-Wide Association Study Plus (MWAS+): A Proof of Concept Study on Drug Repurposing

The high cost and time for developing a new drug or repositioning a partially-developed drug has fueled interest in “repurposing” drugs. Drug repurposing is particularly of interest for Alzheimer’s disease (AD) or AD-related dementias (ADRD) because there are no unrestricted disease-modifying treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yan, Zamrini, Edward, Ahmed, Ali, Wu, Wen-Chih, Shao, Yijun, Zeng-Treitler, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503040/
https://www.ncbi.nlm.nih.gov/pubmed/36135833
http://dx.doi.org/10.3390/medsci10030048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503040/
https://www.ncbi.nlm.nih.gov/pubmed/36135833
http://dx.doi.org/10.3390/medsci10030048

Ejemplares similares